BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33264139)

  • 1. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.
    Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.
    Möller K; Uhlig R; Gorbokon N; Dum D; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Sauter G; Simon R; Bernreuther C; Minner S
    Mol Cell Endocrinol; 2024 Feb; 581():112106. PubMed ID: 37951531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine Markers Insulinoma-Associated Protein 1, Chromogranin, Synaptophysin, and CD56 Show Rare Positivity in Adenocarcinoma Ex-Goblet Cell Carcinoids.
    Yang C; Gonzalez I; Zhang L; Cao D
    Gastroenterology Res; 2019 Jun; 12(3):120-127. PubMed ID: 31236152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
    Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
    Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
    Ting CH; Wang TY; Wu PS
    Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
    Staaf J; Tran L; Söderlund L; Nodin B; Jirström K; Vidarsdottir H; Planck M; Mattsson JSM; Botling J; Micke P; Brunnström H
    Arch Pathol Lab Med; 2020 Sep; 144(9):1075-1085. PubMed ID: 31913660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma.
    Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S
    Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms.
    Zombori T; Turkevi-Nagy S; Sejben A; Juhász-Nagy G; Cserni G; Furák J; Tiszlavicz L; Krenács L; Kővári B
    APMIS; 2021 Apr; 129(4):186-194. PubMed ID: 33417719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.